Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | muscleblind protein 1 | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Echinococcus multilocularis | muscleblind protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Brugia malayi | Muscleblind-like protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Echinococcus granulosus | muscleblind protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable protoporphyrinogen oxidase HemY (protoporphyrinogen-IX oxidase) (protoporphyrinogenase) (PPO) | 0.1758 | 0.8536 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Echinococcus multilocularis | 0.0266 | 0.0339 | 0.0339 | |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0266 | 0.0339 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0266 | 0.0339 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0266 | 0.0339 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0266 | 0.0339 | 0.0339 |
Onchocerca volvulus | 0.0266 | 0.0339 | 0.5 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0266 | 0.0339 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0266 | 0.0339 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0266 | 0.0339 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0266 | 0.0339 | 0.0397 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0266 | 0.0339 | 0.0397 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0266 | 0.0339 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0266 | 0.0339 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0266 | 0.0339 | 0.0108 |
Schistosoma mansoni | amine oxidase | 0.0266 | 0.0339 | 0.0339 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0266 | 0.0339 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0266 | 0.0339 | 0.0339 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0266 | 0.0339 | 0.0108 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0266 | 0.0339 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0266 | 0.0339 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0266 | 0.0339 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0266 | 0.0339 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0266 | 0.0339 | 0.5 |
Echinococcus granulosus | protoporphyrinogen oxidase | 0.1758 | 0.8536 | 1 |
Brugia malayi | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0266 | 0.0339 | 0.0339 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.0339 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 1.0418 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.9093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 6.3096 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.